Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy.
Surgical Pathology and Cytopathology Unit, Department of Medicine (DIMED), University of Padua, Via Gabelli 61, 35121, Padua, Italy.
J Cancer Res Clin Oncol. 2021 Jul;147(7):1897-1904. doi: 10.1007/s00432-021-03589-4. Epub 2021 Mar 12.
Non-neuroendocrine neoplasms of the appendix are a phenotypically heterogeneous group of lesions; a comprehensive molecular characterization of these tumors is still lacking.
A total of 52 samples taken from 49 patients was evaluated: 18 sessile serrated lesions (SSL; 3 with dysplasia), 2 high-grade tubular adenomas, 1 tubulo-villous adenoma,1 hyperplastic polyp, 18 low-grade appendiceal mucinous neoplasms (LAMN), 3 high-grade appendiceal mucinous neoplasms (HAMN) and 9 mucinous adenocarcinomas. Hotspot mutational profiling of the RNF43, SMAD4, KRAS, NRAS, BRAF and PIK3CA genes was performed. Expression of p53, MLH1, PMS2, MSH2, and MSH6 was evaluated by immunohistochemistry.
KRAS was the most frequently mutated gene (53.9% of cases), followed by RNF43 (15.4%), and BRAF (13.5%). In particular: KRAS was mutated in 44.4% of adenocarcinomas, 66.7% of HAMNs, 61.1% of LAMNs, 53.3% of SSL without dysplasia and in 66.7% of SSL with dysplasia; RNF43 was mutated in 33.3% of adenocarcinomas, 66.7% of HAMNs, 11.1% of LAMNs and in 6.7% of SSL without dysplasia; BRAF was mutated in 11.1% of adenocarcinomas, 26.7% of SSL without dysplasia and in 5.6% of LAMNs. Only a case of high-grade tubular adenoma showed mismatch repair deficiency, while immunohistochemical expression of p53 was altered in 21.1% of cases.
The histological phenotypic similarities between appendicular mucinous lesions and serrated colon lesions do not reflect a similar genetic landscape. Mismatch repair deficiency is a rare event during appendiceal mucinous carcinogenesis.
阑尾的非神经内分泌肿瘤是一组表型异质性的病变;这些肿瘤的综合分子特征仍有待阐明。
对 49 例患者的 52 个样本进行评估:18 个无蒂锯齿状病变(SSL;3 个伴异型增生),2 个高级管状腺瘤,1 个管状绒毛状腺瘤,1 个增生性息肉,18 个低级别阑尾黏液性肿瘤(LAMN),3 个高级别阑尾黏液性肿瘤(HAMN)和 9 个黏液性腺癌。对 RNF43、SMAD4、KRAS、NRAS、BRAF 和 PIK3CA 基因进行热点突变分析。通过免疫组织化学评估 p53、MLH1、PMS2、MSH2 和 MSH6 的表达。
KRAS 是最常突变的基因(53.9%的病例),其次是 RNF43(15.4%)和 BRAF(13.5%)。具体而言:KRAS 突变发生在 44.4%的腺癌、66.7%的 HAMN、61.1%的 LAMN、53.3%的无异型增生 SSL 和 66.7%的有异型增生 SSL;RNF43 突变发生在 33.3%的腺癌、66.7%的 HAMN、11.1%的 LAMN 和 6.7%的无异型增生 SSL;BRAF 突变发生在 11.1%的腺癌、26.7%的无异型增生 SSL 和 5.6%的 LAMN。仅 1 例高级管状腺瘤显示错配修复缺陷,而 21.1%的病例存在 p53 免疫组织化学表达改变。
阑尾黏液性病变和锯齿状结肠病变的组织表型相似,但并不反映相似的遗传特征。错配修复缺陷在阑尾黏液性肿瘤发生过程中是一种罕见事件。